ASCO 2026 Highlights

The American Society of Clinical Oncology, or ASCO, Annual Meeting is the world’s largest oncology conference. The meeting brings together cancer experts, thought leaders and professionals from around the world to present groundbreaking research that is changing patient care and moving the field forward.

Drs. Manish Shah and David Nanus discuss some of the most impactful research presented at the 2026 ASCO Annual Meeting. They explore practice-changing advances across a wide range of cancer types, including prostate, pancreatic, lung, kidney, bladder, and colon cancers. Topics include novel targeted therapies such as KRAS and RET inhibitors, emerging radiopharmaceutical treatments, the critical and growing role of tumor sequencing, and the use of circulating tumor DNA (ctDNA) testing and minimal residual disease (MRD) monitoring to guide treatment decisions. The conversation also examines advances in precision medicine, adjuvant therapy strategies, global trends in cancer drug development, and the importance of research funding in developing new treatments for patients.

Guest: David Nanus, MD, Interim Chief, Division of Hematology and Medical Oncology and genitourinary (GU) cancer physician at Weill Cornell Medicine and NewYork-Presbyterian Hospital.

Host: Manish Shah, MD, Chief of Solid Tumor Service and Director of Gastrointestinal Oncology at Weill Cornell Medicine and NewYork-Presbyterian Hospital.